VERTEX PHARMACEUTICALS INC / MA
For the period ended Dec 31, 2025. Filed Feb 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 13, 2026
VRTX$547.89-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accountant Fees and Services
The information required by this Item 14 will be included in the 2026 Proxy Statement and is incorporated herein by
reference. We expect this information to be provided under “Ratification of the Appointment of Independent Registered
Public Accounting Firm.”
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.